收费全文 | 37394篇 |
免费 | 3244篇 |
国内免费 | 64篇 |
耳鼻咽喉 | 381篇 |
儿科学 | 1317篇 |
妇产科学 | 812篇 |
基础医学 | 4988篇 |
口腔科学 | 647篇 |
临床医学 | 4440篇 |
内科学 | 7697篇 |
皮肤病学 | 422篇 |
神经病学 | 3778篇 |
特种医学 | 1157篇 |
外国民族医学 | 2篇 |
外科学 | 4740篇 |
综合类 | 542篇 |
一般理论 | 24篇 |
预防医学 | 4164篇 |
眼科学 | 824篇 |
药学 | 2487篇 |
中国医学 | 54篇 |
肿瘤学 | 2226篇 |
2023年 | 166篇 |
2022年 | 264篇 |
2021年 | 752篇 |
2020年 | 415篇 |
2019年 | 747篇 |
2018年 | 764篇 |
2017年 | 573篇 |
2016年 | 649篇 |
2015年 | 694篇 |
2014年 | 1119篇 |
2013年 | 1607篇 |
2012年 | 2382篇 |
2011年 | 2432篇 |
2010年 | 1279篇 |
2009年 | 1191篇 |
2008年 | 2129篇 |
2007年 | 2232篇 |
2006年 | 2125篇 |
2005年 | 2098篇 |
2004年 | 2068篇 |
2003年 | 1953篇 |
2002年 | 1856篇 |
2001年 | 635篇 |
2000年 | 626篇 |
1999年 | 617篇 |
1998年 | 434篇 |
1997年 | 347篇 |
1996年 | 362篇 |
1995年 | 340篇 |
1994年 | 313篇 |
1993年 | 302篇 |
1992年 | 453篇 |
1991年 | 403篇 |
1990年 | 413篇 |
1989年 | 409篇 |
1988年 | 350篇 |
1987年 | 369篇 |
1986年 | 394篇 |
1985年 | 351篇 |
1984年 | 319篇 |
1983年 | 288篇 |
1982年 | 231篇 |
1981年 | 249篇 |
1980年 | 203篇 |
1979年 | 256篇 |
1978年 | 215篇 |
1976年 | 180篇 |
1975年 | 180篇 |
1974年 | 178篇 |
1973年 | 169篇 |
Method: This systematic review evaluated nine studies which met inclusion criteria in terms of participants, intervention procedures, outcomes and certainty of evidence.
Results: Seven studies revealed a substantial reduction of aggressive behaviour or anger. Certainty of evidence was rated inconclusive in most cases due to absence of experimental control.
Conclusions: We can conclude that body-oriented PMT, involving progressive relaxation and meditation procedure “Soles of the Feet”, is a promising approach. However, the paucity of studies and methodological limitations preclude classifying it as an evidence-based practice. This suggests stronger methodological research and research aimed at PMT’s mechanisms of action (e.g., improved interoceptive awareness) is warranted. 相似文献
Methods: A retrospective cohort design and data from two US healthcare claims repositories were employed. The study population included patients who had non-metastatic cancer of the breast, colon/rectum, lung or ovaries, or non-Hodgkin’s lymphoma (NHL), and who received myelosuppressive chemotherapy regimens with an intermediate/high risk for FN. For each patient, the first cycle of the first course was characterized in terms of PP-CSF use and FN episodes. Crude incidence proportions for PP-CSF and FN during the first cycle were estimated by calendar quarter (2010–2016); multivariable logistic regression models were used to estimate quarter-specific adjusted mean probabilities of FN by PP-CSF use.
Results: The study population totaled 142,730 patients with breast cancer (61%), colorectal cancer (14%), NHL (11%), ovarian cancer (10%) or lung cancer (5%). PP-CSF use increased from 52% in 1Q2010 to 58% in 4Q2016; pegfilgrastim was the most commonly used agent (>96% across quarters). PP-CSF administration on the same day as chemotherapy ranged from 8 to 11% until 1Q2015, and increased to 64% by 4Q2016. Adjusted incidence proportions for FN in the first chemotherapy cycle ranged from 2.7% (95% CI: 2.3–3.0) to 3.7% (95% CI: 3.1–4.3) among those who did not receive PP-CSF, and was 2.6% (95% CI: 2.5–2.7) across quarters among those who received PP-CSF.
Conclusions: Although the use of PP-CSF is commonplace in current US clinical practice, underutilization in cancer patients receiving chemotherapy regimens with an intermediate/high risk for FN may still be an issue. Use of same-day PP-CSF increased markedly from the end of 2015, although this finding reflects (at least in part) increased uptake of pegfilgrastim delivered via an on-body injector as well as the recent change in clinical practice guidelines. Overall, patients receiving PP-CSF appear to have a lower risk of FN during the first cycle of chemotherapy. 相似文献
Methods: A retrospective analysis was performed to identify patients with isolated PCL injuries that underwent reconstruction between 2001 and 2014. Patients with multi-ligamentous injury or another concomitant knee pathology were excluded. Medical records were reviewed for demographic, clinical and operative data. Patients were contacted for administration of a telephone-based questionnaire which included the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation form, Lysholm-Tegner scales, Marx activity scale (MAS), return to sport status, and patient satisfaction instruments.
Results: A total of 15 isolated PCL reconstructions in 14 patients with a mean age of 27.5 years (range 17–43) met the study inclusion criteria; mean follow up was 6.3 years (range 1.4–15.2). Pre-operatively, the primary complaint was knee instability in all patients; on physical examination, lack of a firm end point during posterior drawer testing was found in 93% (14/15) of the knees. In total, 12 of 15 knees underwent transtibial, single-bundle PCLR and three of 15 underwent tibial inlay, double bundle PCLR. Graft types included: quadriceps autograft (7/15), Achilles allograft (6/15), and hamstring autograft (2/15). There were no graft failures in our patient cohort. At most recent follow up the mean scores respectively on the IKDC form, Lysholm-Tegner scales and MAS were (standard deviation): 77.3 (16.5), 83.1 (17.9), 6.13 (2.6), and 7.1 (6.0). All fourteen patients were athletes prior to their injury and 79% (11/14) returned to sport and overall patient satisfaction was 9.2/10.
Conclusions: Isolated PCLR provides good outcomes at mean medium-term follow up with restoration of function, high rate of return to sport and overall patient satisfaction. 相似文献